© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
March 05, 2021
Use of the vasoconstrictor was associated with increased risk for death due to respiratory disorders.
The approval is based on absolute efficacy data from 3 influenza seasons.
Risk was greater in children requiring intensive care, those with chronic kidney disease, and older patients.
March 04, 2021
The study underscores the importance of interpreting patient-reported disease severity scores in the context of mental health factors.